Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription.
By Nina Singh, P. Rogers, C. Atwood, M. Wagener, V. Yu. American Journal of Respiratory and Critical Care Medicine, 2000
989 citations recorded by the source corpus.
Subfields: Critical Care and Intensive Care Medicine, Epidemiology
View Paper: https://www.semanticscholar.org/paper/f1a1d7d514090cae2dcbe05ac59da6d62c40f63d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Critical Care and Intensive Care Medicine
In Epidemiology
Citations in the corpus
- Combating antimicrobial resistance: policy recommendations to save lives. (2011, methodology): “Similarly, following Clinical Pulmonary Infection Scores (CPIS) over time has been used to stop therapy early for nosocomial pneumonia [99].”
- Ventilator-associated lung injury in patients without acute lung injury at the onset of mechanical ventilation* (2004, background): “A clinical pulmonary infection score 6, making a diagnosis of ventilator-associated pneumonia unlikely (24).”
- Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. (2007, background): “Finally, the patient’s condition should be re-evaluated on a regular basis, with appropriate measurements [13,102,103], to decide whether antibiotics should be continued.”
- Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. (2003, result): “To the best of our knowledge, only a few studies have assessed the optimal duration of antimicrobial therapy in patients with VAP.24,40,41 In a recent cohort study of 102 consecutive patients with VAP prospectively evaluated before and after the application of a clinical guideline restricting the to”
- Ventilator-associated pneumonia. (2002, methodology): “When FOB is not available to physicians treating patients clinically suspected of having VAP, we recommend using either a simplified nonbronchoscopic diagnostic procedure, replacing FOB in the algorithm depicted in Figure 1 by one of these techniques, or following the strategy described by Singh and”
- Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. (2008, methodology): “A modified CPIS of 6 or less for 3 days, proposed by Singh and coworkers, is an objective criterion to select patients at low risk for early discontinuation of empiric treatment of HAP, but still requires validation in patients with more severe forms of VAP (Level I) (201, 207).”